Which statement is true about outsourcing facilities with respect to CGMP and inspections?

Which statement is true about outsourcing facilities with respect to CGMP and inspections?

• A. They must comply with CGMP requirements and undergo FDA inspections
• B. They must export to foreign markets
• C. They must register with CBP
• D. They must produce non-sterile drugs

Answer: (A)

Outsourcing facilities are regulated to ensure drug safety and quality through CGMP, and the FDA conducts inspections to verify that those standards are being met. CGMP covers how the facility is designed, how processes are controlled and validated, how personnel are trained, how equipment is maintained, and how finished products are tested and documented. Because patient safety depends on consistent quality, the FDA routinely inspects these facilities to confirm compliance and to enforce corrective actions if issues are found. This is why the correct statement is that they must comply with CGMP requirements and undergo FDA inspections. They are not required to export to foreign markets, CBP registration is not the controlling requirement here, and while many outsourcing facilities focus on sterile products, producing non-sterile drugs is not the defining obligation.

Outsourcing facilities are regulated to ensure drug safety and quality through CGMP, and the FDA conducts inspections to verify that those standards are being met. CGMP covers how the facility is designed, how processes are controlled and validated, how personnel are trained, how equipment is maintained, and how finished products are tested and documented. Because patient safety depends on consistent quality, the FDA routinely inspects these facilities to confirm compliance and to enforce corrective actions if issues are found. This is why the correct statement is that they must comply with CGMP requirements and undergo FDA inspections. They are not required to export to foreign markets, CBP registration is not the controlling requirement here, and while many outsourcing facilities focus on sterile products, producing non-sterile drugs is not the defining obligation.